Cargando…

Corrigendum to “Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease”

Detalles Bibliográficos
Autores principales:	Xie, Yijun, Jia, Yijie, Xie, Cuihua, Hu, Fang, Xue, Meng, Xue, Yaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848053/ https://www.ncbi.nlm.nih.gov/pubmed/29683147 http://dx.doi.org/10.1155/2018/5969714

Ejemplares similares

Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease
por: Xie, Yijun, et al.
Publicado: (2017)

Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy
por: Barutta, Federica, et al.
Publicado: (2013)

[Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1
por: Li, Hong-Lin, et al.
Publicado: (2023)

Human peripheral blood-derived exosomes for microRNA delivery
por: Kang, Ji-Young, et al.
Publicado: (2019)

[Corrigendum] Cross regulation of signaling pathways in gastrointestinal stromal tumor
por: Qi, Yijun, et al.
Publicado: (2023)

Corrigendum to “Exercise Training Restores Cardiac MicroRNA-1 and MicroRNA-29c to Nonpathological Levels in Obese Rats”
por: Silveira, André C., et al.
Publicado: (2018)

[Corrigendum] Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells
por: Zhang, Wenqing, et al.
Publicado: (2023)

Corrigendum to “Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma”
por: Dong, Shuling, et al.
Publicado: (2017)

[Corrigendum] MicroRNA‑92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7
por: Yang, Wei, et al.
Publicado: (2023)

A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles
por: Guo, Jing, et al.
Publicado: (2021)

Corrigendum to “Biomarker MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma Identified Based on Gene Expression Data and MicroRNA-mRNA Network Analysis”
por: Zhang, Hui, et al.
Publicado: (2017)

Corrigendum to “Inguinal Herniation of the Urinary Bladder Presenting as Recurrent Urinary Retention”
por: Frenkel, Amit, et al.
Publicado: (2019)

Corrigendum to “Circulating microRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure”
por: Gao, Guangyuan, et al.
Publicado: (2022)

[Corrigendum] Long non‑coding RNA AC245100.4 promotes prostate cancer tumorigenesis via the microRNA‑145‑5p/RBBP5 axis
por: Xie, Hui, et al.
Publicado: (2023)

Corrigendum to “Plant MicroRNA Prediction by Supervised Machine Learning Using C5.0 Decision Trees”
por: Williams, Philip H., et al.
Publicado: (2017)

Corrigendum to: microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus
Publicado: (2023)

Integrative Gene Expression Profiling Reveals That Dysregulated Triple microRNAs Confer Paclitaxel Resistance in Non-Small Cell Lung Cancer via Cotargeting MAPT [Corrigendum]
Publicado: (2020)

Corrigendum: Mapping of Urinary Schistosomiasis in Anambra State, Nigeria
por: Ndukwe, Yvonne E., et al.
Publicado: (2019)

Corrigendum: Development and validation of urinary exosomal microRNA biomarkers for the diagnosis of acute rejection in kidney transplant recipients
por: Seo, Jung-Woo, et al.
Publicado: (2023)

Corrigendum to ‘microRNA-21a-5p/PDCD4 axis regulates mesenchymal stem cell-induced neuroprotection in acute glaucoma’
por: Su, Wenru, et al.
Publicado: (2023)

MicroRNA-769-5p Promotes the Growth of Glioma Cells by Targeting Lysine Methyltransferase 2A [Corrigendum]
Publicado: (2021)

Corrigendum to “Effect of Narrow-Band Ultraviolet B Phototherapy and Methotrexate on MicroRNA (146a) Levels in Blood of Psoriatic Patients”
por: Abou El-Fadle, Amal, et al.
Publicado: (2016)

Corrigendum to “MicroRNA-30-5p Suppresses Inflammatory Factor-Induced Endothelial Cell Injury by Targeting TCF21”
por: Zhou, Zhenyu, et al.
Publicado: (2021)

Corrigendum for The clinicopathological and microRNA expression signature associated with lymphovascular invasion in squamous cell carcinoma: a basic descriptive study
Publicado: (2022)

Corrigendum
por: Zong, Wubei, et al.
Publicado: (2023)

Corrigendum: Urinary Exosome-Derived microRNAs Reflecting the Changes in Renal Function in Cats
por: Ichii, Osamu, et al.
Publicado: (2019)

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis [Corrigendum]
Publicado: (2022)

Polyethylenimine-based micro/nanoparticles as vaccine adjuvants [Corrigendum]
Publicado: (2017)

Urinary exosomal microRNA profiling in intermediate-risk prostate cancer
por: Kim, Mee Young, et al.
Publicado: (2021)

Corrigendum
por: Sun, Xiao-Hui, et al.
Publicado: (2015)

Corrigendum: Diabetes: how to manage chronic kidney disease
Publicado: (2022)

Circulating Serum Exosomal aHIF Is A Novel Prognostic Predictor For Epithelial Ovarian Cancer [Corrigendum]
Publicado: (2019)

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer [Corrigendum]
Publicado: (2022)

[Corrigendum] Human papillomavirus E6‑regulated microRNA‑20b promotes invasion in cervical cancer by targeting tissue inhibitor of metalloproteinase 2
por: Cheng, Yuan, et al.
Publicado: (2023)

Differential expression profile of urinary exosomal microRNAs in patients with mesangial proliferative glomerulonephritis
por: Dai, Rong, et al.
Publicado: (2023)

Urinary Exosomal MicroRNAs as Biomarkers for Obesity-Associated Chronic Kidney Disease
por: Earle, Angel, et al.
Publicado: (2022)

Bacterial Profile and ESBL Screening of Urinary Tract Infection Among Asymptomatic and Symptomatic Pregnant Women Attending Antenatal Care of Northeastern Ethiopia Region [Corrigendum]
Publicado: (2020)

Corrigendum: ICTV Virus Taxonomy Profile: Ophioviridae
por: García, María Laura, et al.
Publicado: (2018)

Corrigendum: ICTV Virus Taxonomy Profile: Chrysoviridae
por: Ghabrial, Said A., et al.
Publicado: (2018)

Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum]
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_klgqc7n68pj2f3ngngme8ml568